Progesterone Receptor Antibody: Sensitive Detection Tools for Reproductive Research and Endocrine Assays

Concept: Progesterone Physiology and Endocrine Regulation

Progesterone, also termed pregn-4-ene-3,20-dione and abbreviated as Prog or P, is the principal progestogen produced by the ovarian corpus luteum, the adrenal cortex, and the placenta during pregnancy. In non-pregnant adults, progesterone acts synergistically with estrogens to sustain the functional activity of the normal menstrual cycle. After ovulation, the corpus luteum secretes progesterone that converts the endometrium from a proliferative to a secretory state, preparing the tissue for embryo implantation. During pregnancy, the placenta gradually becomes the dominant source of progesterone, and circulating concentrations rise substantially with gestational age. Progesterone maintains implantation and pregnancy progression through several coordinated mechanisms, including suppression of uterine smooth muscle contraction, reduced uterine sensitivity to oxytocin, and promotion of endometrial decidualization. These properties make progesterone a central analyte in studies of reproductive endocrine function.

Research Context: When Progesterone Measurement Is Applied

The sex hormone panel, comprising follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, progesterone, and testosterone, is a routine component of reproductive endocrine assessment in which progesterone carries particular value for evaluating corpus luteum function. Research designs including progesterone measurement typically address menstrual irregularity such as amenorrhea and cycle disturbance, abnormal vaginal bleeding, and perimenopausal transition. Additional applications include aetiological evaluation of female infertility and male infertility, endocrine status assessment before assisted reproductive procedures, and semen parameter abnormalities including oligospermia, asthenospermia, and necrospermia. In male subjects, the sex hormone panel supports assessment of testicular function, spermatogenesis, pituitary function, and erectile dysfunction. Each of these scenarios defines a distinct specimen collection window that must be matched to the biological question.

Interpreting Serum Progesterone Levels in Study Populations

Progesterone concentrations fluctuate cyclically across the menstrual cycle, and this dynamic pattern provides the framework for evaluating ovulatory and luteal function. Follicular phase levels remain low, typically between 0.6 and 1.9 nmol/L. Periovulatory values rise modestly to between 2.40 and 9.40 nmol/L, while the luteal phase shows a marked elevation between 20.7 and 102.4 nmol/L. In research settings, elevated serum progesterone around the periovulatory window, spanning one day either side of ovulation, indicates that ovulation has occurred. Progesterone synthesis increases substantially in multiple gestation, and higher concentrations are also observed in preeclamptic and hypertensive study groups. Conversely, low progesterone levels are characteristic of threatened miscarriage, ectopic gestation, preterm labor, amenorrhea, and infertility cohorts, and corpus luteum insufficiency produces inadequate progesterone secretion. Severe adrenal or thyroid dysfunction can also impair ovarian function, leading to ovulatory disorder and reduced progesterone synthesis.

Antibody Applications in Hormone Detection and Receptor Research

High-specificity antibodies against progesterone underpin accurate hormone quantification. Immunoassay research platforms based on sandwich or competitive formats, including chemiluminescence immunoassay, ELISA, and colloidal gold immunochromatography, depend on well-characterized progesterone antibodies as capture or detection reagents for precise quantification of serum progesterone. Antibodies directed against the progesterone receptor complement this capability by enabling localization studies in hormone-responsive tissues. Immunohistochemical detection of progesterone receptor expression in endometrial and mammary tissue supports evaluation of target tissue responsiveness, and fluorescently labeled conjugates extend these analyses to multiplex imaging and single-cell resolution. Together, soluble hormone quantification and receptor localization describe both the signal and its downstream reception.

Receptor Isoforms and Fluorescent Conjugate Selection

Human T cell responses to progesterone display concentration-dependent effects. At concentrations equivalent to peripheral blood levels, T cell function is only mildly modulated, whereas at concentrations corresponding to the maternal-fetal interface, the cytokine profile shifts markedly, with reduced interferon gamma and tumor necrosis factor alpha secretion and increased interleukin-4 release. Notably, human T cells lack the classical nuclear progesterone receptor, suggesting that membrane progesterone receptors mediate this direct immunomodulatory effect. Two receptor isoforms further diversify signaling. Progesterone receptor B is the transcriptionally active form that activates genes maintaining the endometrium, sustaining pregnancy, and suppressing ovulation, while progesterone receptor A lacks 165 amino acids at the amino terminus, and the exposed inhibitory domain suppresses steroid hormone transcriptional activity. Fluorescent conjugate choice should follow the imaging requirement, with Alexa Fluor 488 supporting conventional and confocal fluorescence microscopy and Alexa Fluor 647 offering an appropriate spectral window for multiplex panels.

Immunoassay Development Workflow for Progesterone Quantification

Building a reliable progesterone immunoassay follows a defined sequence of optimization steps. Method development typically begins with format selection, since the small molecular size of progesterone precludes sandwich configurations and directs designs toward competitive formats using either antibody-coated or antigen-coated solid phases. Tracer concentration, antibody dilution, and incubation time are then titrated to establish a reproducible standard curve spanning the physiological range from follicular through luteal phase concentrations. Specificity verification forms the second phase. Because progesterone is structurally related to other steroid hormones, including pregnenolone, 17-hydroxyprogesterone, and deoxycorticosterone, cross-reactivity testing against these congeners is necessary before a method can be considered qualified. Additional checks against cortisol further define assay selectivity and are routinely reported in published method descriptions.

The third phase addresses specimen handling. Serum and plasma matrices behave differently in competitive formats, so anticoagulant choice and collection timing should be held constant within a study. Because progesterone concentrations vary by more than an order of magnitude across the menstrual cycle, documenting cycle phase at collection is essential for meaningful interpretation, and samples collected at inconsistent phases cannot be compared directly. Lipemic or hemolyzed specimens may introduce interference and are best evaluated during pilot experiments rather than after full-scale collection. Once these parameters are fixed, the antibody supports consistent batch-to-batch performance, which is essential when progesterone concentrations are compared across longitudinal time points. Receptor-directed reagents contribute the complementary dimension, since measuring hormone levels and receptor expression within the same study design describes both ligand availability and tissue responsiveness.

Product Enablement from ANT BIO PTE. LTD.

ANT BIO PTE. LTD. provides validated recombinant rabbit monoclonal antibodies directed against progesterone receptor for reproductive endocrinology research. The Progesterone Receptor Recombinant Rabbit mAb (Alexa Fluor® 488 Conjugate) (S-R123) (S0B0138) and the Progesterone Receptor Recombinant Rabbit mAb (Alexa Fluor® 647 Conjugate) (S-R123) (S0B0134) specifically recognize progesterone receptor protein and undergo rigorous target validation and lot-to-lot quality control. Both reagents suit immunofluorescence, flow cytometry, and confocal microscopy workflows, supporting precise detection needs in progesterone signaling pathway research, reproductive endocrine mechanism studies, and hormone-related disease investigations, with all applications restricted to basic research.

Related Products

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Starter, Absin, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.